{
    "code": "01048733",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01048733",
    "time": "2020-02-14 03:36:10",
    "許可證字號": "衛署藥製字第048733號",
    "廢止狀態": "已廢止",
    "廢止日期": "",
    "廢止理由": "",
    "有效日期": "101\/05\/15",
    "發證日期": "96\/05\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104873305",
    "中文品名": "美善愛麗纖膠囊 10 毫克",
    "英文品名": "Moi-Allison Sibutramine 10mg",
    "適應症": "體重控制計畫之支持療法-BMI 大於或等於30kg\/m2的營養型肥胖病人。-BMI 大於或等於27kg\/m2 併有第二個糖尿病、高血脂等危險因子的營養型體重過重病人。",
    "劑型": "130膠囊劑",
    "包裝": "2~1000顆塑膠瓶裝 鋁箔盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 25監視中學名藥 62完成溶離率試驗",
        "申請商名稱": "0901301200  美時化學製藥股份有限公司",
        "申請商地址": "台北市信義區松仁路277號17樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1212004610",
            "成分名稱": "SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010487330004.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048733&Seq=005&Type=9"
        },
        {
            "title": "010487330003.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048733&Seq=003&Type=8"
        }
    ]
}